文献速递肿瘤 PET/CT

18F-FDG PET影像组学预测宫颈癌无病生存:多扫描仪/多中心研究及外部验证

[18F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner/center study with external validation.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2021-03-26

中位随访23个月后29%患者复发,最佳模型(10个TLR特征+临床信息)AUC为0.78(0.67-0.88)。结论认为影像组学可提供额外预后信息,但性能受PET/CT设备影响。

要点

  • 治疗前18F-FDG PET影像组学联合机器学习可辅助预测局部晚期宫颈癌复发。
  • 最佳模型使用10个肿瘤-肝脏比值特征加临床信息,AUC为0.78(0.67-0.88)。
  • 模型预测性能在不同PET/CT扫描仪间存在差异,ComBat协调未改善最佳模型性能。

核心结论

  • 18F-FDG PET影像组学特征联合机器学习可为局部晚期宫颈癌患者结局提供超越标准临床参数的额外信息,但性能仍受PET/CT设备变异影响。

研究设计与样本

  • 使用Cox比例风险模型检验临床和影像组学特征的统计显著性,五折交叉验证调优特征数量,测试7种特征选择方法和4种分类器。
  • 选定特征的模型通过自助法训练,并在各扫描仪数据中独立测试,评估影像组学特征可重复性、临床数据附加价值及基于ComBat的协调效果。

主要发现

  • 中位随访23个月后,29%的患者复发。
  • 没有任何单个影像组学或临床特征与癌症复发显著相关。
  • 最佳模型使用10个TLR特征联合临床信息,AUC为0.78(0.67-0.88),F1分数为0.49(0.25-0.67),精确率为0.42(0.25-0.60),召回率为0.63(0.20-0.80)。
  • ComBat协调未改善最佳模型的预测性能。
  • TLR模型和原生模型在测试集所用不同扫描仪间性能均有变化。

临床怎么用

  • 治疗前18F-FDG PET/CT影像组学联合机器学习模型可用于局部晚期宫颈癌复发风险分层,但需考虑扫描仪差异对模型性能的影响。

局限性

  • 模型性能在不同PET/CT扫描仪间存在变异,ComBat协调未改善最佳模型预测性能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To test the performances of native and tumour to liver ratio (TLR) radiomic features extracted from pre-treatment 2-[18F] fluoro-2-deoxy-D-glucose ([18F]FDG) PET/CT and combined with machine learning (ML) for predicting cancer recurrence in patients with locally advanced cervical cancer (LACC). METHODS: One hundred fifty-eight patients with LACC from multiple centers were retrospectively included in the study. Tumours were segmented using the Fuzzy Local Adaptive Bayesian (FLAB) algorithm. Radiomic features were extracted from the tumours and from regions drawn over the normal liver. Cox proportional hazard model was used to test statistical significance of clinical and radiomic features. Fivefold cross validation was used to tune the number of features. Seven different feature selection methods and four classifiers were tested. The models with the selected features were trained using bootstrapping and tested in data from each scanner independently. Reproducibility of radiomics features, clinical data added value and effect of ComBat-based harmonisation were evaluated across scanners. RESULTS: After a median follow-up of 23 months, 29% of the patients recurred. No individual radiomic or clinical features were significantly associated with cancer recurrence. The best model was obtained using 10 TLR features combined with clinical information. The area under the curve (AUC), F1-score, precision and recall were respectively 0.78 (0.67-0.88), 0.49 (0.25-0.67), 0.42 (0.25-0.60) and 0.63 (0.20-0.80). ComBat did not improve the predictive performance of the best models. Both the TLR and the native models performance varied across scanners used in the test set. CONCLUSION: [18F]FDG PET radiomic features combined with ML add relevant information to the standard clinical parameters in terms of LACC patient's outcome but remain subject to variability across PET/CT devices.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Ferreira M, Lovinfosse P, Hermesse J, et al. [18F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner/center study with external validation. Eur J Nucl Med Mol Imaging. 2021. PMID: 33772334. doi:10.1007/s00259-021-05303-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。